BioXcel Therapeutics Inc (FRA:BX2)
€ 1.892 0.006 (0.32%) Market Cap: 72.49 Mil Enterprise Value: 98.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

BioXcel Therapeutics Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 06:30PM GMT
Release Date Price: €19.18 (-4.96%)
Chris Howerton
(Trades, Portfolio) LLC - Moderator

Okay. I think we're about to get started here. Thank you, everybody, for joining us. My name is Chris Howerton, part of the Jefferies biotechnology research team.

Really excited to be seeing everybody here at our conference. And then, of course, to be hosting a fireside chat with BioXcel. So thanks for joining us, gentlemen. Vimal and the team are here with us. So thank you so much.

Okay. So maybe, Vimal, I'll start off with you. If you could maybe just start off and maybe give us a bit of an overview or an elevator pitch of the company.

Vimal Mehta
BioXcel Therapeutics, Inc. - CEO

Happy to do that.

First of all, thank you for hosting us here and for the fireside chat. And good

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot